Fangsheng Pharmaceutical announced that the company's product indobufen tablets and bisoprolol amlodipine tablets, a wholly-owned subsidiary of Fangsheng Jianmeng, will be selected for the 12th batch of nationally organized drugs for centralized volume procurement. The procurement period is until December 31, 2029. None of the above products have been officially sold, and there is no sales data.

Zhitongcaijing · 2d ago
Fangsheng Pharmaceutical announced that the company's product indobufen tablets and bisoprolol amlodipine tablets, a wholly-owned subsidiary of Fangsheng Jianmeng, will be selected for the 12th batch of nationally organized drugs for centralized volume procurement. The procurement period is until December 31, 2029. None of the above products have been officially sold, and there is no sales data.